BioRestorative Therapies' CEO to Speak at ROTH Conference

BioRestorative Therapies' CEO to Address Investment Opportunities

BioRestorative Therapies, Inc. (NASDAQ: BRTX), a leader in regenerative medicine, will have its Chief Executive Officer, Lance Alstodt, present at the 3rd Annual ROTH Healthcare Opportunities Conference. Set for October 9, 2024, this event will provide a platform for direct interaction between BioRestorative and potential investors.

Engagement Through One-on-One Meetings

The conference emphasizes personalized interactions, featuring a series of one-on-one investor meetings designed to facilitate discussions. Investors interested in scheduling a meeting with BioRestorative are encouraged to reach out to their ROTH MKM sales representatives to arrange these connections.

Discover BioRestorative Therapies' Innovative Solutions

Founded with a vision to advance the field of regenerative medicine, BioRestorative Therapies is dedicated to developing therapeutic products through innovative cell and tissue protocols. The company primarily focuses on adult stem cells, with two core clinical development programs in the areas of chronic pain and metabolic disorders.

Overview of Key Programs

BioRestorative's first critical initiative, known as brtxDISC™, showcases its lead cell therapy candidate, BRTX-100. This product leverages a patient’s own cultured mesenchymal stem cells, which are harvested from bone marrow, to potentially treat painful lumbosacral disc disorders without the need for invasive surgery. Through a careful process involving the isolation and cryopreservation of these stem cells, BRTX-100 represents a significant innovation in non-surgical treatment methods.

Addressing Metabolic Disorders

The second program, ThermoStem®, is another exciting venture, where BioRestorative aims to tackle obesity and related metabolic disorders. Their research utilizes brown adipose-derived stem cells (BADSC) to create brown adipose tissue (BAT), which has shown promise in enhancing calorie burning and regulating metabolic processes. In early studies, increased levels of BAT have been linked to healthier metabolic outcomes, including lower risks of obesity and diabetes.

Cosmetic Innovations with BioCosmeceuticals

In addition to its medical therapies, BioRestorative Therapies is expanding into the cosmetic industry with its BioCosmeceuticals line. The company recently launched a cell-based secretome serum designed to combat signs of aging, such as fine lines and wrinkles. This product, developed in a state-of-the-art cGMP ISO-7 certified clean room, exemplifies the company's commitment to quality and innovation in aesthetic products.

Future Directions and Research Initiatives

BioRestorative's leadership looks to the future with an excitement for growth in both their therapeutic and cosmetic offerings. The company plans to broaden its range of cell-based products while navigating the pathway to receive U.S. Food and Drug Administration (FDA) approvals for its innovative aesthetic treatments. Such advancements would not only enhance the value of BioRestorative’s portfolio but also signal a shift in how regenerative products can be utilized in both medical and cosmetic fields.

Get in Touch with the Company

For those interested in learning more about BioRestorative Therapies' initiatives or to inquire about potential investment opportunities, the company encourages contact with their Investor Relations team. The designated contact for inquiries is Stephen Kilmer, who can be reached directly at (646) 274-3580 or via email.

Frequently Asked Questions

What is BioRestorative Therapies known for?

BioRestorative Therapies focuses on developing stem cell-based therapeutics, specifically in pain management and metabolic disorders.

Who will represent BioRestorative at the ROTH conference?

CEO Lance Alstodt will represent BioRestorative Therapies at the conference, discussing company innovations and investment opportunities.

What are the main programs BioRestorative is working on?

The main programs include the brtxDISC™ for spine conditions and ThermoStem® for metabolic disorders using stem cell technology.

How do BioRestorative's products work?

Their products utilize a patient’s own stem cells or derived substances to promote healing, treat disorders, and improve cosmetic appearance.

How can investors get in touch with BioRestorative?

Investors can arrange meetings through ROTH MKM sales representatives or contact Investor Relations for more information.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.